Making transfusion safer
Nature Medicine
December 28, 2009
A molecule has been identified that can elicit a deadly immune response after blood transfusion, as reported in this week’s Nature Medicine.
Transfusion-related acute lung injury (TRALI) is a frequent cause of death after blood transfusion. TRALI is often caused by antibodies found in blood components that are directed against a protein, HNA-3a. The identity of these antibodies has so far remained unknown.
Andreas Greinacher and colleagues now show that HNA-3a is coded by the choline transporter-like protein-2 gene, and that genetic variants in this molecule change the reactivity of the protein with HNA-3a-specific antibodies.
The molecular identification of this antigen should facilitate the development of tests for blood donor screening to lower the risk of TRALI.
doi: 10.1038/nm.2070
Research highlights
-
Dec 8
Ecology: Make-up of a two-million-year-old ecosystem reconstructed from ancient DNANature
-
Dec 8
Genetics: Large GWAS identifies variants associated with drinking and smokingNature
-
Dec 7
Evolution: Ruminant ears help trace 35 million years of evolutionNature Communications
-
Dec 7
Microbiology: Links between human gut bacteria and depression assessedNature Communications
-
Dec 6
Infectious diseases: Organoid research facilitates a new potential approach to protect from COVID-19Nature
-
Dec 2
Palaeontology: New predatory diving dinosaur species identifiedCommunications Biology
